Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

344
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
344
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

238
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
238
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

369
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
369
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

2.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

416
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
416
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

1.3K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.

Acta dermato-venereologica·2026
Same author

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

JAMA dermatology·2026
Same author

SOX9/Kruppel-like factor 5 and the infiltrating epidermal hyperplasia of hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
Same author

Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study.

Frontiers in immunology·2026
Same author

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Dermatology and therapy·2025
Same author

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.

Journal of the American Academy of Dermatology·2025

Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.5K

Hidradenitis suppurativa.

Robert Sabat1, Gregor B E Jemec2, Łukasz Matusiak3

  • 1Psoriasis Research and Treatment Center, Charité - Universitätsmedizin Berlin, Berlin, Germany. robert.sabat@charite.de.

Nature Reviews. Disease Primers
|March 14, 2020
PubMed
Summary
This summary is machine-generated.

Hidradenitis suppurativa (HS), a chronic skin condition, causes painful nodules and tunnels, impacting quality of life. Understanding HS pathogenesis is crucial for developing better treatments for this prevalent disorder.

More Related Videos

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.8K
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.7K

Related Experiment Videos

Last Updated: Dec 26, 2025

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.5K
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.8K
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.7K

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory skin disease affecting approximately 1% of the population.
  • It manifests as painful nodules, abscesses, and tunnels in intertriginous areas, often starting in early adulthood.
  • HS is linked to significant comorbidities, including metabolic and cardiovascular disorders, reducing life expectancy.

Purpose of the Study:

  • To summarize the current understanding of Hidradenitis Suppurativa (HS) pathogenesis.
  • To highlight the impact of HS on patients' quality of life.
  • To underscore the need for increased awareness and novel therapeutic strategies for HS.

Main Methods:

  • Review of existing literature on HS etiology, pathogenesis, and clinical presentation.
  • Analysis of the role of immune system activation and inflammatory cytokines in HS development.
  • Examination of current therapeutic options and unmet needs in HS management.

Main Results:

  • HS pathogenesis involves genetic predisposition, environmental factors (smoking, obesity), and hormonal influences.
  • Immune system activation, particularly involving TNF, IL-1β, and IL-17, drives chronic inflammation, tissue destruction, and scarring.
  • HS significantly impairs quality of life, leading to social, emotional, and economic consequences.

Conclusions:

  • Effective HS management requires a multi-faceted approach including antibiotics, anti-TNF therapy, surgery, and lifestyle changes.
  • There is a critical need for greater public and professional awareness of HS.
  • Further research into HS pathogenesis is essential for developing more targeted and effective treatments.